Literature DB >> 29928795

EGF Regulates the Interaction of Tks4 with Src through Its SH2 and SH3 Domains.

Metta Dülk1, Bálint Szeder1, Gábor Glatz2, Balázs L Merő1, Kitti Koprivanacz1, Gyöngyi Kudlik1, Virág Vas1, Szabolcs Sipeki3, Anna Cserkaszky1, László Radnai1, László Buday1,3.   

Abstract

The nonreceptor tyrosine kinase Src is a central component of the epidermal growth factor (EGF) signaling pathway. Our group recently showed that the Frank-ter Haar syndrome protein Tks4 (tyrosine kinase substrate with four Src homology 3 domains) is also involved in EGF signaling. Here we demonstrate that Tks4 and Src bind directly to each other and elucidate the details of the molecular mechanism of this complex formation. Results of GST pull-down and fluorescence polarization assays show that both a proline-rich SH3 binding motif (PSRPLPDAP, residues 466-474) and an adjacent phosphotyrosine-containing SH2 binding motif (pYEEI, residues 508-511) in Tks4 are responsible for Src binding. These motifs interact with the SH3 and SH2 domains of Src, respectively, leading to a synergistic enhancement of binding strength and a highly stable, "bidentate"-type of interaction. In agreement with these results, we found that the association of Src with Tks4 is permanent and the complex lasts at least 3 h in living cells. We conclude that the interaction of Tks4 with Src may result in the long term stabilization of the kinase in its active conformation, leading to prolonged Src activity following EGF stimulation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29928795     DOI: 10.1021/acs.biochem.8b00084

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer.

Authors:  Qianping Li; Weijie Ma; Tianhong Li
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  De novo design of tyrosine and serine kinase-driven protein switches.

Authors:  Nicholas B Woodall; Zara Weinberg; Jesslyn Park; Florian Busch; Richard S Johnson; Mikayla J Feldbauer; Michael Murphy; Maggie Ahlrichs; Issa Yousif; Michael J MacCoss; Vicki H Wysocki; Hana El-Samad; David Baker
Journal:  Nat Struct Mol Biol       Date:  2021-09-13       Impact factor: 18.361

3.  A Novel Cell-Based Model for a Rare Disease: The Tks4-KO Human Embryonic Stem Cell Line as a Frank-Ter Haar Syndrome Model System.

Authors:  Loretta László; Hédi Maczelka; Tamás Takács; Anita Kurilla; Álmos Tilajka; László Buday; Virag Vas; Ágota Apáti
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

4.  Intersection of TKS5 and FGD1/CDC42 signaling cascades directs the formation of invadopodia.

Authors:  Anna Zagryazhskaya-Masson; Pedro Monteiro; Anne-Sophie Macé; Alessia Castagnino; Robin Ferrari; Elvira Infante; Aléria Duperray-Susini; Florent Dingli; Arpad Lanyi; Damarys Loew; Elisabeth Génot; Philippe Chavrier
Journal:  J Cell Biol       Date:  2020-09-07       Impact factor: 10.539

5.  Analysis of Tks4 Knockout Mice Suggests a Role for Tks4 in Adipose Tissue Homeostasis in the Context of Beigeing.

Authors:  Virag Vas; Tamás Háhner; Gyöngyi Kudlik; Dávid Ernszt; Krisztián Kvell; Dániel Kuti; Krisztina J Kovács; József Tóvári; Mária Trexler; Balázs L Merő; Bálint Szeder; Kitti Koprivanacz; László Buday
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

6.  Absence of the Tks4 Scaffold Protein Induces Epithelial-Mesenchymal Transition-Like Changes in Human Colon Cancer Cells.

Authors:  Bálint Szeder; Júlia Tárnoki-Zách; Dóra Lakatos; Virág Vas; Gyöngyi Kudlik; Balázs Merő; Kitti Koprivanacz; László Bányai; Lilla Hámori; Gergely Róna; András Czirók; András Füredi; And László Buday
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

7.  Epidermal Growth Factor Protects Against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation.

Authors:  Yan Sun; Ming Deng; Xiao Ke; Xiangyang Lei; Hao Ju; Zhiming Liu; Xiaosu Bai
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-19       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.